
West Pharmaceutical Services, Inc. – NYSE:WST
West Pharmaceutical Services stock price today
West Pharmaceutical Services stock price monthly change
West Pharmaceutical Services stock price quarterly change
West Pharmaceutical Services stock price yearly change
West Pharmaceutical Services key metrics
Market Cap | 23.87B |
Enterprise value | 23.94B |
P/E | 48.55 |
EV/Sales | 8.32 |
EV/EBITDA | 32.19 |
Price/Sales | 8.39 |
Price/Book | 8.81 |
PEG ratio | 3.12 |
EPS | 7.68 |
Revenue | 2.92B |
EBITDA | 811.6M |
Income | 568.7M |
Revenue Q/Q | -2.95% |
Revenue Y/Y | 1.56% |
Profit margin | 17.37% |
Oper. margin | 20.02% |
Gross margin | 34.92% |
EBIT margin | 20.02% |
EBITDA margin | 27.71% |
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeWest Pharmaceutical Services stock price history
West Pharmaceutical Services stock forecast
West Pharmaceutical Services financial statements
$393
Potential upside: 59.12%
Analysts Price target
Financials & Ratios estimates
Jun 2023 | 753.8M | 155.1M | 20.58% |
---|---|---|---|
Sep 2023 | 747.4M | 161.3M | 21.58% |
Dec 2023 | 732M | 137M | 18.72% |
Mar 2024 | 695.4M | 115.3M | 16.58% |
Payout ratio | 11.73% |
---|
2019 | 0.41% |
---|---|
2020 | 0.23% |
2021 | 0.15% |
2022 | 0.31% |
2023 | 0.22% |
Jun 2023 | 3669600000 | 922.9M | 25.15% |
---|---|---|---|
Sep 2023 | 3754700000 | 886.5M | 23.61% |
Dec 2023 | 3829500000 | 948.5M | 24.77% |
Mar 2024 | 3602300000 | 921.7M | 25.59% |
Jun 2023 | 169.2M | -82.1M | -176.8M |
---|---|---|---|
Sep 2023 | 230.1M | -95.7M | -22.3M |
Dec 2023 | 239.1M | -108.8M | -189.5M |
Mar 2024 | 118.2M | -90.6M | -271M |
West Pharmaceutical Services alternative data
Aug 2023 | 10,700 |
---|---|
Sep 2023 | 10,700 |
Oct 2023 | 10,700 |
Nov 2023 | 10,700 |
Dec 2023 | 10,700 |
Jan 2024 | 10,700 |
Feb 2024 | 10,700 |
Mar 2024 | 10,600 |
Apr 2024 | 10,600 |
May 2024 | 10,600 |
Jun 2024 | 10,600 |
Jul 2024 | 10,600 |
West Pharmaceutical Services other data
Period | Buy | Sel |
---|---|---|
Dec 2023 | 0 | 1013 |
Feb 2024 | 0 | 73163 |
Mar 2024 | 0 | 815 |
May 2024 | 0 | 66000 |
Jun 2024 | 0 | 1800 |
Aug 2024 | 0 | 31761 |
Oct 2024 | 0 | 703 |
Transaction | Date | Insider | Security | Shares | Price per share | Total value | Source |
---|---|---|---|---|---|---|---|
Option | WITHERSPOON CHARLES officer: VP & Treasurer | Common Stock | 478 | $173.22 | $82,799 | ||
Sale | WITHERSPOON CHARLES officer: VP & Treasurer | Common Stock | 478 | $310.4 | $148,371 | ||
Sale | WITHERSPOON CHARLES officer: VP & Treasurer | Common Stock | 225 | $310.4 | $69,840 | ||
Option | WITHERSPOON CHARLES officer: VP & Treasurer | Stock Options (Right to Buy) | 478 | $173.22 | $82,799 | ||
Option | ABRAHAM SILJI officer: SVP, Chi.. | Common Stock | 458 | N/A | N/A | ||
Option | ABRAHAM SILJI officer: SVP, Chi.. | Rst. Stock Unit | 458 | N/A | N/A | ||
Option | WITHERSPOON CHARLES officer: VP & Treasurer | Common Stock | 529 | $102.51 | $54,228 | ||
Sale | WITHERSPOON CHARLES officer: VP & Treasurer | Common Stock | 529 | $300 | $158,700 | ||
Sale | WITHERSPOON CHARLES officer: VP & Treasurer | Common Stock | 500 | $300 | $150,000 | ||
Option | WITHERSPOON CHARLES officer: VP & Treasurer | Stock Options (Right to Buy) | 529 | $102.51 | $54,228 |
Patent |
---|
Application Filling date: 2 Mar 2022 Issue date: 8 Sep 2022 |
Application Filling date: 22 Jul 2020 Issue date: 11 Aug 2022 |
Application Filling date: 5 Apr 2022 Issue date: 21 Jul 2022 |
Application Filling date: 14 May 2020 Issue date: 14 Jul 2022 |
Grant Utility: Pharmaceutical syringe piston Filling date: 15 Mar 2019 Issue date: 28 Jun 2022 |
Grant Utility: Electronic plunger assembly Filling date: 18 Oct 2019 Issue date: 21 Jun 2022 |
Application Filling date: 25 Jan 2020 Issue date: 16 Jun 2022 |
Grant Filling date: 17 Dec 2018 Issue date: 10 May 2022 |
Grant Design: Injection needle shield puller Filling date: 6 Nov 2020 Issue date: 12 Apr 2022 |
Grant Utility: System and method for testing closure integrity of a sealed container at cryogenic temperatures Filling date: 25 Nov 2019 Issue date: 22 Mar 2022 |
Quarter | Transcript |
---|---|
Q1 2024 25 Apr 2024 | Q1 2024 Earnings Call Transcript |
Q4 2023 15 Feb 2024 | Q4 2023 Earnings Call Transcript |
Q3 2023 10 Nov 2023 | Q3 2023 Earnings Call Transcript |
Q2 2023 27 Jul 2023 | Q2 2023 Earnings Call Transcript |
Using SA's Stock Screener: Sell 6 Overvalued Blue Chips, With Stagnating Growth
West Pharmaceutical Services: A Solid Buy For Long-Term Investors
West Pharmaceutical Services: The Run Might Be Over
West Pharmaceutical: Revise To Buy On Exceptional Economic Characteristics
Lifecore: Highly Skewed Special Situation
Healthcare's Hidden Gem: West Pharmaceutical Services
West Pharmaceutical: A Growing Company, But Pass On Its Declining Margin Outlook
U.S. Wide-Moat Stocks On Sale: The January 2023 Heat Map
U.S. Wide-Moat Stocks On Sale - The December 2022 Heat Map
-
What's the price of West Pharmaceutical Services stock today?
One share of West Pharmaceutical Services stock can currently be purchased for approximately $246.98.
-
When is West Pharmaceutical Services's next earnings date?
Unfortunately, West Pharmaceutical Services's (WST) next earnings date is currently unknown.
-
Does West Pharmaceutical Services pay dividends?
Yes, West Pharmaceutical Services pays dividends and its trailing 12-month yield is 0.24% with 12% payout ratio. The last West Pharmaceutical Services stock dividend of $0.18 was paid on 2 Feb 2022.
-
How much money does West Pharmaceutical Services make?
West Pharmaceutical Services has a market capitalization of 23.87B and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 2.18% to 2.95B US dollars.
-
What is West Pharmaceutical Services's stock symbol?
West Pharmaceutical Services, Inc. is traded on the NYSE under the ticker symbol "WST".
-
What is West Pharmaceutical Services's primary industry?
Company operates in the Healthcare sector and Medical - Instruments & Supplies industry.
-
How do i buy shares of West Pharmaceutical Services?
Shares of West Pharmaceutical Services can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
Who are West Pharmaceutical Services's key executives?
West Pharmaceutical Services's management team includes the following people:
- Mr. Eric M. Green Pres, Chief Executive Officer & Director(age: 55, pay: $3,100,000)
- Mr. Bernard J. Birkett Senior Vice President & Chief Financial Officer(age: 56, pay: $1,460,000)
- Mr. David A. Montecalvo Senior Vice President and Chief Operations & Supply Chain Officer(age: 60, pay: $1,040,000)
- Mr. Silji Abraham Senior Vice President & Chief Technology Officer(age: 53, pay: $1,030,000)
-
How many employees does West Pharmaceutical Services have?
As Jul 2024, West Pharmaceutical Services employs 10,600 workers.
-
When West Pharmaceutical Services went public?
West Pharmaceutical Services, Inc. is publicly traded company for more then 45 years since IPO on 17 Mar 1980.
-
What is West Pharmaceutical Services's official website?
The official website for West Pharmaceutical Services is westpharma.com.
-
Where are West Pharmaceutical Services's headquarters?
West Pharmaceutical Services is headquartered at 530 Herman O. West Drive, Exton, PA.
-
How can i contact West Pharmaceutical Services?
West Pharmaceutical Services's mailing address is 530 Herman O. West Drive, Exton, PA and company can be reached via phone at +61 5942900.
-
What is West Pharmaceutical Services stock forecast & price target?
Based on 1 Wall Street analysts` predicted price targets for West Pharmaceutical Services in the last 12 months, the avarage price target is $393. The average price target represents a 59.12% change from the last price of $246.98.
West Pharmaceutical Services company profile:

West Pharmaceutical Services, Inc.
westpharma.comNYSE
10,600
Medical - Instruments & Supplies
Healthcare
West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhance the safe delivery of drugs through advanced reconstitution, mixing, and transfer technologies; and films, coatings, washing, and vision inspection and sterilization processes and services to enhance the quality of packaging components. It also provides drug containment solutions, including Crystal Zenith, a cyclic olefin polymer in the form of vials, syringes, and cartridges; and self-injection devices, as well as a range of integrated solutions, including analytical lab services, pre-approval primary packaging support and engineering development, regulatory expertise, and after-sales technical support. This segment serves biologic, generic, and pharmaceutical drug companies. The Contract-Manufactured Products segment is involved in the design, manufacture, and automated assembly of devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products. It serves pharmaceutical, diagnostic, and medical device companies. The company distributes its products through its sales force and distribution network, as well as contract sales agents and regional distributors. West Pharmaceutical Services, Inc. was incorporated in 1923 and is headquartered in Exton, Pennsylvania.
Exton, PA 19341-0645
CIK: 0000105770
ISIN: US9553061055
CUSIP: 955306105